Global Pathogen Surveillance Initiative (GPSI): Decentralized Sequencing, Real-Time Reporting, and Equitable Data Governance
Description
Establish a Global Pathogen Surveillance Initiative (GPSI) combining three components: (1) Decentralized Sequencing Network: Fund 500 regional sequencing labs across Africa, South Asia, Southeast Asia, and Latin America — bringing sequencing capacity to the locations where novel pathogens are most likely to emerge.
Each lab equipped with nanopore sequencing technology (now cost-effective at <$10K per setup) and trained staff. Connect via open-access sequencing platforms (ONT's EPI2ME or equivalent) that allow any lab to upload sequences and get real-time variant calling and surveillance alerts.
(2) Real-Time Reporting Protocol: Binding international agreement requiring all countries to report sequences of any novel pathogen to GPSI within 48 hours of sequencing — with transparent, real-time data access to all signatories. Modeled on the EWRS (Early Warning and Response System) in Europe but global and more stringent.
(3) Equitable Data Governance: Genetic data from low-income countries countries belongs to those countries — any commercial development based on sequences triggers royalty-sharing to the source country. g. H5N1 sequencing negotiations between Indonesia and WHO).
Implementation Pathway
Phase 1 (2026–2027)
- • Fund 100 sequencing labs in highest-risk regions
- • GPSI reporting protocol finalized and adopted by 50 countries
- • Real-time data platform operational
Phase 2 (2027–2030)
- • 500 labs operational
- • GPSI membership reaches 150 countries
- • First novel pathogen detected and characterized within 48-72 hours of emergence
Phase 3 (2030+)
- • GPSI becomes de facto global surveillance standard
- • Detection-to-characterization time falls below 72 hours globally
- • Pandemic preparedness becomes reactive response to characterized threats, not detective work
Required Resources
Impact Analysis
Overall Net Impact
Combined analysis across all timeframes
Short-term
0-2 years
No benefits identified
No harms identified
Mid-term
3-10 years
No benefits identified
No harms identified
Long-term
10+ years
No benefits identified
No harms identified
